5-epi-Isofagomine structure
|
Common Name | 5-epi-Isofagomine | ||
---|---|---|---|---|
CAS Number | 169105-89-9 | Molecular Weight | 147.17 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 317.2±37.0 °C at 760 mmHg | |
Molecular Formula | C6H13NO3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 171.8±17.1 °C |
Use of 5-epi-IsofagomineAfegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
Name | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol |
---|---|
Synonym | More Synonyms |
Description | Afegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 317.2±37.0 °C at 760 mmHg |
Molecular Formula | C6H13NO3 |
Molecular Weight | 147.17 |
Flash Point | 171.8±17.1 °C |
PSA | 72.72000 |
LogP | -1.80 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.535 |
IFM |
5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE |
(3R,4R,5S)-5-(Hydroxymethyl)piperidine-3,4-diol |
5-epi-Isofagomine |
3,4-Piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5S)- |
iso-Fagomine |
(3R,4R,5S)-5-(Hydroxymethyl)-3,4-piperidinediol |
1oif |
D-Isofagomine |
Afegostat |